Phrixus Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
Safety and Efficacy of P-188 NF in DMD Patients
Phase 2
Terminated
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Drug: P-188 NF
- First Posted Date
- 2018-06-15
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Phrixus Pharmaceuticals, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT03558958
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath